Dr. Duker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Washington St
# 450
Boston, MA 02111Phone+1 617-636-4677Fax+1 617-636-4866
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Surgical Retina and Vitreous, 2011- Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1985 - 1991
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1984 - 1985- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1984
Certifications & Licensure
MA State Medical License 1990 - 2025
PA State Medical License 1985 - 1990
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- Boston Magazine Castle Connolly, 2008-2013
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Join now to see all
Clinical Trials
- Eplerenone for Central Serous Chorioretinopathy Start of enrollment: 2013 May 01
Publications & Presentations
PubMed
- Evaluating Blood Flow Speed in Retinal Microaneurysms Secondary to Diabetic Retinopathy Using Variable Interscan Time Analysis OCTA.Hiroyuki Takahashi, Yunchan Hwang, Jungeun Won, Muhammad Usman Jamil, Antonio Yaghy
Translational Vision Science & Technology. 2025-02-03 - High-Resolution OCT Reveals Age-Associated Variation in the Region Posterior to the External Limiting Membrane.Muhammad Usman Jamil, Jungeun Won, Stefan B Ploner, Anna Marmalidou, Hiroyuki Takahashi
Translational Vision Science & Technology. 2025-01-02 - 4 citations15-Gene Expression Profile andas Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1).J William Harbour, Zelia M Correa, Amy C Schefler, Prithvi Mruthyunjaya, Miguel A Materin
Journal of Clinical Oncology. 2024-10-01
Journal Articles
- Model-to-Data Approach for Deep Learning in Optical Coherence Tomography Intraretinal Fluid SegmentationCecilia S Lee, Jay S Duker, Nadia K Waheed, JAMA Ophthalmology
Authored Content
- Model-to-Data Approach for Deep Learning in Optical Coherence Tomography Intraretinal Fluid SegmentationAugust 2020
- Model-to-Data Approach for Deep Learning in Optical Coherence Tomography Intraretinal Fluid SegmentationAugust 2020
Press Mentions
EyePoint Announces Positive 6-Month Results for the Phase 2 VERONA Clinical Trial of Duravyu for DMEJanuary 16th, 2025- EyePoint Pharma Announces Positive Interim Results for Duravyu in Phase 2 VERONA Trial for DMEOctober 28th, 2024
- EyePoint Pharmaceuticals Doses First Patient in Phase 3 LUGANO Trial for Wet AMD Therapy DuravyuOctober 24th, 2024
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
